Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,138,732 papers from all fields of science
Search
Sign In
Create Free Account
Cytidine Deaminase Inhibitor
Any substance that inhibits cytidine deaminase, an enzyme that scavenges exogenous and endogenous cytidine and 2'-deoxycytidine for UMP synthesis…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
A Phase 2 Dose-Confirmation Study of Oral ASTX727, a Combination of Oral Decitabine with a Cytidine Deaminase Inhibitor (CDAi) Cedazuridine (E7727), in Subjects with Myelodysplastic Syndromes (MDS)
G. Garcia-Manero
,
E. Griffiths
,
+13 authors
M. Savona
2017
Corpus ID: 217187980
Poster can be downloaded from www.astx.com ASTX727-PB17(701) Abstract # 4274 Guillermo Garcia-Manero 1, Elizabeth A. Griffiths2…
Expand
2008
2008
Optimized blood sampling with cytidine deaminase inhibitor for improved analysis of capecitabine metabolites.
T. Besnard
,
N. Renée
,
M. Etienne-Grimaldi
,
E. François
,
G. Milano
Journal of chromatography. B, Analytical…
2008
Corpus ID: 26075415
2007
2007
Quantitative determination of the cytidine deaminase inhibitor tetrahydrouridine (THU) in mouse plasma by liquid chromatography/electrospray ionization tandem mass spectrometry.
R. Parise
,
M. Egorin
,
J. Eiseman
,
E. Joseph
,
J. Covey
,
J. Beumer
Rapid Communications in Mass Spectrometry
2007
Corpus ID: 39297782
A number of anticancer drugs are cytidine analogues that undergo metabolic deactivation catalyzed by cytidine deaminase (CD). 3,4…
Expand
2002
2002
Analytical and pharmacokinetic studies with 5-chloro-2'-deoxycytidine.
J. T. Hale
,
J. Bigelow
,
L. Mathews
,
J. McCormack
Biochemical Pharmacology
2002
Corpus ID: 1915112
1998
1998
Accumulation of arabinosyluracil 5'-triphosphate during arabinosylcytosine therapy in circulating blasts of patients with acute myelogenous leukemia.
V. Gandhi
,
Y. Z. Xu
,
E. Estey
Clinical Cancer Research
1998
Corpus ID: 24568046
Arabinosylcytosine (ara-C) is the most effective nucleoside analogue for treatment of acute myelogenous leukemia. The…
Expand
1995
1995
Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
S. Grant
,
A. Turner
,
P. Nelms
,
S. Yanovich
Leukemia
1995
Corpus ID: 24883155
We have assessed the response of a previously characterized multidrug resistant (MDR) human erythroleukemia cell line (K562R) to…
Expand
1989
1989
Selective radiosensitization and cytotoxicity of human melanoma cells using halogenated deoxycytidines and tetrahydrouridine.
T. Lawrence
,
M. Davis
International Journal of Radiation Oncology…
1989
Corpus ID: 30262503
1986
1986
Deoxycytidine stimulates the in vitro growth of normal CFU-GM and reverses the negative regulatory effects of acidic isoferritin and prostaglandin E1.
K. Bhalla
,
J. Cole
,
+4 authors
S. Grant
Blood
1986
Corpus ID: 8868471
We have examined the effect of supraphysiologic concentrations of the naturally occurring nucleoside deoxycytidine (dCyd) on the…
Expand
Review
1978
Review
1978
ARA-C analogs.
P. Alberto
Antibiotics and Chemotherapy
1978
Corpus ID: 2296977
Ara-C, a phase-specific antitumor agent, is rapidly deactivated by the enzyme cytidine deaminase. A prolongation of the…
Expand
1975
1975
Deoxycytidine transport in the presence of a cytidine deaminase inhibitor and the transport of uracil in Escherichia coli B.
P. V. Dippe
,
K. Leung
,
S. Roy-Burman
,
D. Visser
Journal of Biological Chemistry
1975
Corpus ID: 38851133
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE